» Articles » PMID: 38761367

Menopause Depression: Under Recognised and Poorly Treated

Abstract

Menopause is a biological process experienced by all people assigned female at birth. A significant number of women experience mental ill health related to the major brain gonadal hormone shifts that occur in their midlife. There is poor understanding and management of the complex mental ill health issues, with the biological brain hormone changes receiving little formal attention. The current treatment advice is to manage this special type of mental ill health in the same way that all mental ill health is managed. This leads to poor outcomes for women and their families. Many women leave the workforce earlier than expected due to menopause-related depression and anxiety, with subsequent loss of salary and superannuation. Others describe being unable to adequately parent or maintain meaningful relationships - all ending in a poor quality of life. We are a large and diverse group of national and international clinicians, lived experience and social community advocates, all working together to innovate the current approaches available for women with menopausal mental ill health. Above all, true innovation is only possible when the woman with lived experience of menopause is front and centre of this debate.

Citing Articles

Using estrogen and progesterone to treat premenstrual dysphoric disorder, postnatal depression and menopausal depression.

Mu E, Chiu L, Kulkarni J Front Pharmacol. 2025; 16:1528544.

PMID: 40051565 PMC: 11882533. DOI: 10.3389/fphar.2025.1528544.


The intersection between menopause and depression: overview of research using animal models.

Herrera-Perez J, Hernandez-Hernandez O, Flores-Ramos M, Cueto-Escobedo J, Rodriguez-Landa J, Martinez-Mota L Front Psychiatry. 2024; 15:1408878.

PMID: 39081530 PMC: 11287658. DOI: 10.3389/fpsyt.2024.1408878.

References
1.
Freeman E . Depression in the menopause transition: risks in the changing hormone milieu as observed in the general population. Womens Midlife Health. 2019; 1:2. PMC: 6214217. DOI: 10.1186/s40695-015-0002-y. View

2.
Blazer D, Kessler R, McGonagle K, Swartz M . The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry. 1994; 151(7):979-86. DOI: 10.1176/ajp.151.7.979. View

3.
Rossouw J, Anderson G, Prentice R, LaCroix A, Kooperberg C, Stefanick M . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288(3):321-33. DOI: 10.1001/jama.288.3.321. View

4.
Dennerstein L, Guthrie J, Clark M, Lehert P, Henderson V . A population-based study of depressed mood in middle-aged, Australian-born women. Menopause. 2004; 11(5):563-8. DOI: 10.1097/01.gme.0000113844.74462.f6. View

5.
Cohen L, Soares C, Vitonis A, Otto M, Harlow B . Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry. 2006; 63(4):385-90. DOI: 10.1001/archpsyc.63.4.385. View